Sources growth-equity opportunities for technology and healthcare companies across North America, combining deal origination with hands-on operational support to accelerate scale. Joel Top leverages prior operating roles and investor networks to underwrite revenue-driven business models and lead board-level execution. Background includes product and commercial leadership, with experience deploying capital across Series A–C rounds; education includes business school and engineering roots.
Sources growth-equity opportunities for technology and healthcare companies across North America, combining deal origination with hands-on operational support to accelerate scale. Joel Top leverages prior operating roles and investor networks to underwrite revenue-driven business models and lead board-level execution. Background includes product and commercial leadership, with experience deploying capital across Series A–C rounds; education includes business school and engineering roots.
Focuses on growth-equity investments in North American technology and healthcare companies, prioritizing revenue-driven models with clear unit economics and repeatable go-to-market engines. Combines rigorous commercial underwriting with hands-on operational support and board-level leadership to accelerate scale, de-risk execution, and structure follow-on capital. Targets Series A–C opportunities with a 3–7 year horizon, emphasizing measurable growth KPIs, disciplined capital allocation, and an operator-led playbook to optimize product and commercialization.
Focuses on growth-equity investments in North American technology and healthcare companies, prioritizing revenue-driven models with clear unit economics and repeatable go-to-market engines. Combines rigorous commercial underwriting with hands-on operational support and board-level leadership to accelerate scale, de-risk execution, and structure follow-on capital. Targets Series A–C opportunities with a 3–7 year horizon, emphasizing measurable growth KPIs, disciplined capital allocation, and an operator-led playbook to optimize product and commercialization.
| Trades 284 | Longs Won 195/284 68% | Profit Factor 5.4 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $291,369.11 |
| Average Win $149,942.06 | Best Trade (Oct 14) $2.31M | Sharpe Ratio -126.59 |
| Average Loss -$60,830.78 | Worst Trade (Mar 30) -$970,262.92 | Z-Score -2.45 (100%) |
| Commissions $0 | Avg. Trade Length 5m 2d | Expectancy $83,890.01 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 2,358 | 2,123 | 1,887 | 1,651 | 1,415 | 1,179 | 943 | 708 | 472 | 236 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AGG iShares Core U.S. Aggregate Bond ETF | 5,721 | $569,901.84 | $545,668.98 | - | -$24,232.86 | -4.25% | +0.591% |
AVEM Avantis Emerging Markets Equity ETF | 39,579 | $3.68M | $3.56M | - | -$118,088.93 | -3.21% | -1.099% |
AVIG Avantis Core Fixed Income ETF | 90,260 | $3.77M | $3.59M | - | -$184,102.04 | -4.88% | +0.57% |
AVLV Avantis U.S. Large Cap Value ETF | 21,368 | $1.8M | $1.99M | - | $186,008.2 | 10.32% | +0.416% |
AVUS Avantis U.S. Equity ETF | 126,080 | $14.02M | $16.31M | - | $2.29M | 16.36% | +0.093% |
BFRZ Innovator Equity Managed 100 Buffer ETF | 52,368 | $1.38M | $1.43M | - | $46,510.2 | 3.37% | +0.026% |
BUFD FT Cboe Vest U.S. Equity Deep Buffer ETF - December | 13,703 | $396,153.69 | $418,558.13 | - | $22,404.44 | 5.66% | 0.0 |
BUFF Innovator Laddered Allocation Fund | 38,381 | $1.97M | $2.08M | - | $116,045.44 | 5.91% | +0.065% |
DFAI Dimensional International Core Equity Market ETF | 92,813 | $3.62M | $3.83M | - | $217,646.48 | 6.02% | +0.279% |
DFAS Dimensional U.S. Small Cap ETF | 47,652 | $3.83M | $3.71M | - | -$119,247.68 | -3.12% | +0.705% |
DFSD Dimensional Short-Duration Fixed Income ETF | 23,700 | $1.14M | $1.11M | - | -$30,773.25 | -2.7% | +0.193% |
EWC iShares MSCI Canada ETF | 26,432 | $1.45M | $1.58M | - | $129,988.71 | 8.97% | +0.852% |
EWI iShares MSCI Italy ETF | 27,248 | $1.46M | $1.53M | - | $70,586.86 | 4.84% | -0.062% |
EWJ iShares MSCI Japan ETF | 17,795 | $1.5M | $1.69M | - | $184,792.19 | 12.29% | -0.991% |
EWU iShares MSCI United Kingdom ETF | 31,610 | $1.51M | $1.51M | - | -$3,178.07 | -0.21% | +1.556% |
FDHY Fidelity Enhanced High Yield ETF | 23,155 | $1.14M | $1.1M | - | -$30,796.5 | -2.71% | +0.315% |
FLQM Franklin U.S. Mid Cap Multifactor Index Fund | 11,605 | $655,333.88 | $698,795.07 | - | $43,461.19 | 6.63% | +1.594% |
HGER Harbor Commodity All-Weather Fund | 104,199 | $3.25M | $3.76M | - | $514,903.01 | 15.85% | -0.345% |
HYMB SPDR Nuveen ICE High Yield Municipal Bond ETF | 34,083 | $854,966.97 | $809,300.83 | - | -$45,666.14 | -5.34% | +1.172% |
ICVT iShares Convertible Bond ETF | 41,005 | $4.99M | $4.35M | - | -$640,498.4 | -12.83% | -0.404% |